ASX - By Stock
|
RAC |
Re:
RAC media coverage
|
|
ReNova
|
2.2K |
741K |
7 |
21/06/24 |
21/06/24 |
ASX - By Stock
|
2.2K
|
741K
|
7
|
|
ASX - By Stock
|
RAC |
Re:
RAC media coverage
|
|
ReNova
|
2.2K |
741K |
7 |
20/06/24 |
20/06/24 |
ASX - By Stock
|
2.2K
|
741K
|
7
|
|
ASX - By Stock
|
RAC |
Re:
RAC media coverage
|
|
ReNova
|
2.2K |
741K |
38 |
20/06/24 |
20/06/24 |
ASX - By Stock
|
2.2K
|
741K
|
38
|
|
ASX - By Stock
|
RAC |
Re:
Industry news
|
|
ReNova
|
1.7K |
613K |
7 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
1.7K
|
613K
|
7
|
|
ASX - By Stock
|
RAC |
Re:
Industry news
|
|
ReNova
|
1.7K |
613K |
6 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
1.7K
|
613K
|
6
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Application for quotation of securities - RAC
|
|
ReNova
|
35 |
10K |
7 |
30/05/24 |
30/05/24 |
ASX - By Stock
|
35
|
10K
|
7
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
ReNova
|
11K |
3.8M |
8 |
27/05/24 |
27/05/24 |
General
|
11K
|
3.8M
|
8
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
ReNova
|
605 |
182K |
3 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
605
|
182K
|
3
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Notification of cessation of securities - RAC
|
|
ReNova
|
64 |
19K |
24 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
64
|
19K
|
24
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race releases complete cardio-protection data & video
|
|
ReNova
|
227 |
85K |
11 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
227
|
85K
|
11
|
|
ASX - By Stock
|
RAC |
Re:
RAC media coverage
|
|
ReNova
|
2.2K |
741K |
4 |
08/02/24 |
08/02/24 |
ASX - By Stock
|
2.2K
|
741K
|
4
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
ReNova
|
605 |
182K |
9 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
605
|
182K
|
9
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
ReNova
|
21K |
7.3M |
1 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
21K
|
7.3M
|
1
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
ReNova
|
21K |
7.3M |
3 |
31/01/24 |
31/01/24 |
ASX - By Stock
|
21K
|
7.3M
|
3
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
ReNova
|
11K |
3.8M |
18 |
25/01/24 |
25/01/24 |
General
|
11K
|
3.8M
|
18
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
ReNova
|
11K |
3.8M |
38 |
11/01/24 |
11/01/24 |
General
|
11K
|
3.8M
|
38
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
ReNova
|
605 |
182K |
14 |
09/01/24 |
09/01/24 |
ASX - By Stock
|
605
|
182K
|
14
|
|
ASX - By Stock
|
RAC |
Re:
Cardioprotection thread
|
|
ReNova
|
605 |
182K |
8 |
01/01/24 |
01/01/24 |
ASX - By Stock
|
605
|
182K
|
8
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Updated Strategy and Investor Presentation
|
|
ReNova
|
508 |
125K |
5 |
05/12/23 |
05/12/23 |
ASX - By Stock
|
508
|
125K
|
5
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Updated Strategy and Investor Presentation
|
|
ReNova
|
508 |
125K |
6 |
05/12/23 |
05/12/23 |
ASX - By Stock
|
508
|
125K
|
6
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Updated Strategy and Investor Presentation
|
|
ReNova
|
508 |
125K |
2 |
04/12/23 |
04/12/23 |
ASX - By Stock
|
508
|
125K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Updated Strategy and Investor Presentation
|
|
ReNova
|
508 |
125K |
3 |
04/12/23 |
04/12/23 |
ASX - By Stock
|
508
|
125K
|
3
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Zantrene highly effective in EMD AML Mouse Model
|
|
ReNova
|
115 |
43K |
5 |
01/12/23 |
01/12/23 |
ASX - By Stock
|
115
|
43K
|
5
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Zantrene highly effective in EMD AML Mouse Model
|
|
ReNova
|
115 |
43K |
38 |
01/12/23 |
01/12/23 |
ASX - By Stock
|
115
|
43K
|
38
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Updated Strategy and Investor Presentation
|
|
ReNova
|
508 |
125K |
17 |
30/11/23 |
30/11/23 |
ASX - By Stock
|
508
|
125K
|
17
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Zantrene highly effective in EMD AML Mouse Model
|
|
ReNova
|
115 |
43K |
22 |
30/11/23 |
30/11/23 |
ASX - By Stock
|
115
|
43K
|
22
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bonus Options Prospectus
|
|
ReNova
|
226 |
55K |
7 |
23/11/23 |
23/11/23 |
ASX - By Stock
|
226
|
55K
|
7
|
|
ASX - By Stock
|
RAC |
Re:
Why Analysts Believe RAC is “Highly Undervalued”
|
|
ReNova
|
137 |
61K |
16 |
14/11/23 |
14/11/23 |
ASX - By Stock
|
137
|
61K
|
16
|
|
ASX - By Stock
|
RAC |
Re:
Why Analysts Believe RAC is “Highly Undervalued”
|
|
ReNova
|
137 |
61K |
17 |
14/11/23 |
14/11/23 |
ASX - By Stock
|
137
|
61K
|
17
|
|
ASX - By Stock
|
RAC |
Re:
Why Analysts Believe RAC is “Highly Undervalued”
|
|
ReNova
|
137 |
61K |
24 |
14/11/23 |
14/11/23 |
ASX - By Stock
|
137
|
61K
|
24
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bisantrene cGMP API Manufacturing Completed at Laurus Labs
|
|
ReNova
|
74 |
27K |
3 |
27/09/23 |
27/09/23 |
ASX - By Stock
|
74
|
27K
|
3
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bisantrene cGMP API Manufacturing Completed at Laurus Labs
|
|
ReNova
|
74 |
27K |
5 |
27/09/23 |
27/09/23 |
ASX - By Stock
|
74
|
27K
|
5
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bisantrene Shows Broad Anti-Cancer Activity in Cancer Cells
|
|
ReNova
|
218 |
73K |
3 |
22/09/23 |
22/09/23 |
ASX - By Stock
|
218
|
73K
|
3
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bisantrene Shows Broad Anti-Cancer Activity in Cancer Cells
|
|
ReNova
|
218 |
73K |
3 |
21/09/23 |
21/09/23 |
ASX - By Stock
|
218
|
73K
|
3
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
ReNova
|
11K |
3.8M |
4 |
20/09/23 |
20/09/23 |
General
|
11K
|
3.8M
|
4
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
ReNova
|
11K |
3.8M |
16 |
19/09/23 |
19/09/23 |
General
|
11K
|
3.8M
|
16
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
ReNova
|
21K |
7.3M |
1 |
14/09/23 |
14/09/23 |
ASX - By Stock
|
21K
|
7.3M
|
1
|
|
ASX - By Stock
|
RAC Biotech |
Re:
Large BUY - ex insider/ ex CSO / new consultant - Dr Tillett
|
|
ReNova
|
143 |
51K |
8 |
08/09/23 |
08/09/23 |
ASX - By Stock
|
143
|
51K
|
8
|
|
ASX - By Stock
|
RAC Biotech |
Re:
Large BUY - ex insider/ ex CSO / new consultant - Dr Tillett
|
|
ReNova
|
143 |
51K |
19 |
05/09/23 |
05/09/23 |
ASX - By Stock
|
143
|
51K
|
19
|
|
ASX - By Stock
|
RAC Biotech |
Re:
Large BUY - ex insider/ ex CSO / new consultant - Dr Tillett
|
|
ReNova
|
143 |
51K |
3 |
05/09/23 |
05/09/23 |
ASX - By Stock
|
143
|
51K
|
3
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Board and Management Team Changes
|
|
ReNova
|
450 |
149K |
11 |
01/09/23 |
01/09/23 |
ASX - By Stock
|
450
|
149K
|
11
|
|
ASX - By Stock
|
RAC Biotech |
Re:
Large BUY - ex insider/ ex CSO / new consultant - Dr Tillett
|
|
ReNova
|
143 |
51K |
8 |
31/08/23 |
31/08/23 |
ASX - By Stock
|
143
|
51K
|
8
|
|
ASX - By Stock
|
RAC Biotech |
Re:
Large BUY - ex insider/ ex CSO / new consultant - Dr Tillett
|
|
ReNova
|
143 |
51K |
25 |
31/08/23 |
31/08/23 |
ASX - By Stock
|
143
|
51K
|
25
|
|
ASX - By Stock
|
RAC |
Re:
Industry news
|
|
ReNova
|
1.7K |
613K |
5 |
30/08/23 |
30/08/23 |
ASX - By Stock
|
1.7K
|
613K
|
5
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Strategic Update August 2023
|
|
ReNova
|
592 |
188K |
13 |
09/08/23 |
09/08/23 |
ASX - By Stock
|
592
|
188K
|
13
|
|
ASX - By Stock
|
RAC |
Re:
Industry news
|
|
ReNova
|
1.7K |
613K |
8 |
07/08/23 |
07/08/23 |
ASX - By Stock
|
1.7K
|
613K
|
8
|
|
ASX - By Stock
|
RAC |
Re:
ANN - Issuing of the official RACE Playlist
|
|
ReNova
|
32 |
9.8K |
2 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
32
|
9.8K
|
2
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
ReNova
|
11K |
3.8M |
10 |
28/07/23 |
28/07/23 |
General
|
11K
|
3.8M
|
10
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
ReNova
|
11K |
3.8M |
2 |
27/07/23 |
27/07/23 |
General
|
11K
|
3.8M
|
2
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
ReNova
|
11K |
3.8M |
18 |
26/07/23 |
26/07/23 |
General
|
11K
|
3.8M
|
18
|
|